Literature DB >> 20848236

Patients admitted with acute abdominal conditions are at high risk for venous thromboembolism but often fail to receive adequate prophylaxis.

Emily A Pearsall1, Ujash Sheth, Darlene S Fenech, Margaret E McKenzie, J Charles Victor, Robin S McLeod.   

Abstract

INTRODUCTION: The aim was to determine the frequency with which thromboprophylaxis is prescribed, factors predicting its prescription, and the frequency of symptomatic venous thromboembolism in patients admitted with acute abdominal conditions.
METHODS: Charts of patients admitted with acute abdominal conditions that did not have surgery for at least 24 h following admission were audited to identify if thromboprophylaxis was prescribed, if it was prescribed appropriately, factors affecting its prescription, and the rate of symptomatic venous thromboembolism.
RESULTS: Of 350 patients (176 females, mean age 64.9 ± 18.6), 194 (55.4%) were admitted for bowel obstruction, 113 (32.3%) for biliary conditions, 14 (4.0%) for diverticulitis, 8 (2.3%) for pancreatitis, and 21 (6.0%) for other conditions. One hundred forty-two (40.6%) underwent surgery. Two hundred fifty-two (72.0%, 95% CI 67.3-76.7%) received thromboprophylaxis although only 199 (56.9%, 95% CI 51.7-62.1%) received adequate thromboprophylaxis. Hospital site and having surgery were associated with prescription of thromboprophylaxis. Twelve patients (3.4%, 95% CI 1.5-4.3%) developed symptomatic venous thromboembolism (nine deep venous thrombosis, three pulmonary embolism).
CONCLUSIONS: Despite patients admitted with acute abdominal conditions being at high risk for development of symptomatic venous thromboembolism, many do not receive adequate thromboprophylaxis. Further work is required to decrease this gap in care.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20848236     DOI: 10.1007/s11605-010-1334-4

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  16 in total

1.  A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project.

Authors:  Giancarlo Agnelli; Giorgio Bolis; Lorenzo Capussotti; Roberto Mario Scarpa; Francesco Tonelli; Erminio Bonizzoni; Marco Moia; Fabio Parazzini; Romina Rossi; Francesco Sonaglia; Bettina Valarani; Carlo Bianchini; Gualberto Gussoni
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

2.  Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.

Authors:  Alexander T Cohen; Bruce L Davidson; Alexander S Gallus; Michael R Lassen; Martin H Prins; Witold Tomkowski; Alexander G G Turpie; Jan F M Egberts; Anthonie W A Lensing
Journal:  BMJ       Date:  2006-01-26

3.  Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates.

Authors:  Jason M Stinnett; Robert Pendleton; Leanne Skordos; Michelle Wheeler; George M Rodgers
Journal:  Am J Hematol       Date:  2005-03       Impact factor: 10.047

4.  Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?

Authors:  D A Sandler; J F Martin
Journal:  J R Soc Med       Date:  1989-04       Impact factor: 5.344

Review 5.  Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients.

Authors:  Alexander T Cohen; Raza Alikhan; Juan I Arcelus; Jean-François Bergmann; Sylvia Haas; Geno J Merli; Alex C Spyropoulos; Victor F Tapson; Alexander G G Turpie
Journal:  Thromb Haemost       Date:  2005-10       Impact factor: 5.249

6.  A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.

Authors:  M M Samama; A T Cohen; J Y Darmon; L Desjardins; A Eldor; C Janbon; A Leizorovicz; H Nguyen; C G Olsson; A G Turpie; N Weisslinger
Journal:  N Engl J Med       Date:  1999-09-09       Impact factor: 91.245

7.  Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey.

Authors:  Jean-Francois Bergmann; Alexander T Cohen; Victor F Tapson; Samuel Z Goldhaber; Ajay K Kakkar; Bruno Deslandes; Wei Huang; Frederick A Anderson
Journal:  Thromb Haemost       Date:  2010-02-02       Impact factor: 5.249

8.  Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study.

Authors:  Raza Alikhan; Alexander T Cohen; Sophie Combe; Meyer M Samama; Louis Desjardins; Amiram Eldor; Charles Janbon; Alain Leizorovicz; Carl-Gustav Olsson; Alexander G G Turpie
Journal:  Arch Intern Med       Date:  2004-05-10

9.  Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  William H Geerts; David Bergqvist; Graham F Pineo; John A Heit; Charles M Samama; Michael R Lassen; Clifford W Colwell
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

10.  Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.

Authors:  Alain Leizorovicz; Alexander T Cohen; Alexander G G Turpie; Carl-Gustav Olsson; Paul T Vaitkus; Samuel Z Goldhaber
Journal:  Circulation       Date:  2004-08-02       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.